{"nct_id":"NCT02251717","title":"Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2014-10-14","start_date_type":"ACTUAL","primary_completion_date":"2016-03-24","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}